{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:05:32Z","timestamp":1792598732648,"version":"4.5.0"},"reference-count":39,"publisher":"American Association for Cancer Research (AACR)","issue":"9","funder":[{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-CT06-17"],"award-info":[{"award-number":["SU2C-AACR-CT06-17"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014547","name":"Parker Institute for Cancer Immunotherapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA197633"],"award-info":[{"award-number":["R35CA197633"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA168585"],"award-info":[{"award-number":["P01CA168585"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004322","name":"Agilent Technologies","doi-asserted-by":"publisher","award":["Agilent Thought Leader Award"],"award-info":[{"award-number":["Agilent Thought Leader Award"]}],"id":[{"id":"10.13039\/100004322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019319","name":"Ressler Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007186","name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000043","name":"American Association for Cancer Research","doi-asserted-by":"publisher","award":["SU2C-AACR-CT06-17"],"award-info":[{"award-number":["SU2C-AACR-CT06-17"]}],"id":[{"id":"10.13039\/100000043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["SU2C-AACR-CT06-17"],"award-info":[{"award-number":["SU2C-AACR-CT06-17"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","award":["Irvington Program"],"award-info":[{"award-number":["Irvington Program"]}],"id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019319","name":"Ressler Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007186","name":"Jonsson Comprehensive Cancer Center, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180888"],"award-info":[{"award-number":["U10CA180888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180819"],"award-info":[{"award-number":["U10CA180819"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180821"],"award-info":[{"award-number":["U10CA180821"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA18068"],"award-info":[{"award-number":["U10CA18068"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180888"],"award-info":[{"award-number":["U10CA180888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180819"],"award-info":[{"award-number":["U10CA180819"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>In the phase II trial SWOG S1616 (NCT03033576), patients with advanced melanoma with primary resistance to anti\u2013programmed cell death protein 1 (PD-1)\/programmed cell death ligand 1 (PD-L1) therapies had improved outcomes with the combination of the anti\u2013cytotoxic T lymphocyte\u2013associated protein 4 (CTLA-4) antibody ipilimumab with continued anti\u2013PD-1 therapy with nivolumab, compared with ipilimumab alone. Baseline biopsies from patients responsive to combination therapy showed increased transcriptomic expression of complement by myeloid cells, interferon pathways by endothelial cells, and oxidative phosphorylation and lipid metabolism by melanoma cells. Using spatial proteomics, some on-therapy biopsies from patients responding to combination therapy exhibited networks of activated CD8 T cells near melanoma cells, whereas others had T and myeloid cells, reflecting different time points in a dynamic antitumor response. Conversely, biopsies from patients progressing on combination immunotherapy displayed impaired T-cell infiltration adjacent to plasma cells. Our results define cellular neighborhoods and transcriptomes in melanoma biopsies when reversing resistance to anti\u2013PD-1 with the addition of anti\u2013CTLA-4, and plasma cell sheets in nonresponding biopsies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Patients with melanoma with primary resistance to anti\u2013PD-1\/PD-L1 therapies are treated with anti\u2013PD-1 in combination with anti\u2013CTLA-4. Melanoma biopsies responding to combination immunotherapy in the second line of care have distinct tumor microenvironments, with antitumor immune responses, compared with those that progress, which have impaired T-cell infiltration and plasma cell networks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-25-1745","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:02:29Z","timestamp":1776801749000},"page":"1801-1818","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti\u2013CTLA-4 in Melanoma with Primary Resistance to Anti\u2013PD-1"],"prefix":"10.1158","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-4432","authenticated-orcid":false,"given":"Katie M.","family":"Campbell","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."},{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 2 Jonsson Comprehensive Cancer Center, , Los Angeles, California."},{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6660-6257","authenticated-orcid":false,"given":"Daniel G.","family":"Chen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 4 David Geffen School of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2516-2166","authenticated-orcid":false,"given":"Zaid E.","family":"Bustami","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0666-4791","authenticated-orcid":false,"given":"Nataly","family":"Naser Al Deen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3284-5329","authenticated-orcid":false,"given":"Egmidio","family":"Medina","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2251-618X","authenticated-orcid":false,"given":"Cynthia R.","family":"Gonzalez","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4931-6519","authenticated-orcid":false,"given":"Jessica","family":"Maxey","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-8574","authenticated-orcid":false,"given":"Marshall A.","family":"Thompson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-0245","authenticated-orcid":false,"given":"Sarah","family":"Samorodnitsky","sequence":"additional","affiliation":[{"name":"5SWOG Statistics and Data Management Center, Seattle, Washington."},{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 6 , Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-7106","authenticated-orcid":false,"given":"Lawrence F.","family":"Kuklinski","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 7 Division of Dermatology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4690-3905","authenticated-orcid":false,"given":"Ivan","family":"Perez Garcilazo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-4690","authenticated-orcid":false,"given":"Ignacio","family":"Baselga-Carretero","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-0517","authenticated-orcid":false,"given":"Agustin","family":"Vega-Crespo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-9143","authenticated-orcid":false,"given":"Jia Ming","family":"Chen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 8 Parker Institute for Cancer Immunotherapy Center, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1059-824X","authenticated-orcid":false,"given":"Rangasamy","family":"Elumalai","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02tryst02","id-type":"ROR","asserted-by":"publisher"}],"name":"Agilent Technologies 9 , Santa Clara, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2407-3288","authenticated-orcid":false,"given":"Marc","family":"Visitacion","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02tryst02","id-type":"ROR","asserted-by":"publisher"}],"name":"Agilent Technologies 9 , Santa Clara, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9410-8674","authenticated-orcid":false,"given":"Rob","family":"Schiemann","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0064-5565","authenticated-orcid":false,"given":"Lacey","family":"Padron","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3262-0853","authenticated-orcid":false,"given":"Cadence","family":"Chang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4632-6383","authenticated-orcid":false,"given":"Alan E.","family":"Zelin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5863-203X","authenticated-orcid":false,"given":"Sai S.","family":"Chelluri","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 4 David Geffen School of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6352-160X","authenticated-orcid":false,"given":"Silvia","family":"Boffo","sequence":"additional","affiliation":[{"name":"10Bristol Myers Squibb, Princeton, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-6689","authenticated-orcid":false,"given":"Kari L.","family":"Kendra","sequence":"additional","affiliation":[{"name":"11Ohio State University Wexner Medical Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-3320","authenticated-orcid":false,"given":"Bartosz","family":"Chmielowski","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 12 , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-2557","authenticated-orcid":false,"given":"Thach-Giao","family":"Truong","sequence":"additional","affiliation":[{"name":"13Kaiser Permanente Northern California, Kaiser Permanente NCORP, Vallejo, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3636-4143","authenticated-orcid":false,"given":"Nikhil I.","family":"Khushalani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01xf75524","id-type":"ROR","asserted-by":"publisher"}],"name":"Moffitt Cancer Center 14 Department of Cutaneous Oncology, , Tampa, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9807-4240","authenticated-orcid":false,"given":"Frances","family":"Collichio","sequence":"additional","affiliation":[{"name":"15Division of Oncology, Department of Medicine, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4448-9755","authenticated-orcid":false,"given":"Alexandra P.","family":"Ikeguchi","sequence":"additional","affiliation":[{"name":"16University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7130-7366","authenticated-orcid":false,"given":"Adrienne I.","family":"Victor","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/022kthw22","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Rochester 17 , Rochester, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5248-4356","authenticated-orcid":false,"given":"Kim A.","family":"Margolin","sequence":"additional","affiliation":[{"name":"18St. John\u2019s Cancer Institute, Santa Monica, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-773X","authenticated-orcid":false,"given":"Douglas B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"19Vanderbilt-Ingram Cancer Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4175-8055","authenticated-orcid":false,"given":"Yuanbin","family":"Chen","sequence":"additional","affiliation":[{"name":"20Cancer and Hematology Centers of Western Michigan\/Cancer Research Consortium of West Michigan, Grand Rapids, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-9698","authenticated-orcid":false,"given":"Jeffrey A.","family":"Sosman","sequence":"additional","affiliation":[{"name":"21Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-1517","authenticated-orcid":false,"given":"Sapna P.","family":"Patel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04twxam07","id-type":"ROR","asserted-by":"publisher"}],"name":"The University of Texas MD Anderson Cancer Center 22 , Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-4710","authenticated-orcid":false,"given":"Siwen","family":"Hu-Lieskovan","sequence":"additional","affiliation":[{"name":"23University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4195-6694","authenticated-orcid":false,"given":"James","family":"Moon","sequence":"additional","affiliation":[{"name":"5SWOG Statistics and Data Management Center, Seattle, Washington."},{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 6 , Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2463-3139","authenticated-orcid":false,"given":"Daniel K.","family":"Wells","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-4390","authenticated-orcid":false,"given":"Christine N.","family":"Spencer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5934-6715","authenticated-orcid":false,"given":"Shay","family":"Bellasea","sequence":"additional","affiliation":[{"name":"5SWOG Statistics and Data Management Center, Seattle, Washington."},{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 6 , Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-2563","authenticated-orcid":false,"given":"Ari M.","family":"Vanderwalde","sequence":"additional","affiliation":[{"name":"24The West Clinic, Wolf River, Germantown, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-6570","authenticated-orcid":false,"given":"Michael C.","family":"Wu","sequence":"additional","affiliation":[{"name":"5SWOG Statistics and Data Management Center, Seattle, Washington."},{"id":[{"id":"https:\/\/ror.org\/007ps6h72","id-type":"ROR","asserted-by":"publisher"}],"name":"Fred Hutchinson Cancer Center 6 , Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2563-2042","authenticated-orcid":false,"given":"Philip O.","family":"Scumpia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 2 Jonsson Comprehensive Cancer Center, , Los Angeles, California."},{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 4 David Geffen School of Medicine, , Los Angeles, California."},{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 7 Division of Dermatology, Department of Medicine, , Los Angeles, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3669-8458","authenticated-orcid":false,"given":"Antoni","family":"Ribas","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 1 Division of Hematology-Oncology, Department of Medicine, , Los Angeles, California."},{"id":[{"id":"https:\/\/ror.org\/046rm7j60","id-type":"ROR","asserted-by":"publisher"}],"name":"University of California, Los Angeles 2 Jonsson Comprehensive Cancer Center, , Los Angeles, California."},{"id":[{"id":"https:\/\/ror.org\/0184qbg02","id-type":"ROR","asserted-by":"publisher"}],"name":"Parker Institute for Cancer Immunotherapy 3 , San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"2026090103080751800_bib1","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","article-title":"Immune checkpoint therapy-current perspectives and future directions","volume":"186","author":"Sharma","year":"2023","journal-title":"Cell"},{"key":"2026090103080751800_bib2","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"key":"2026090103080751800_bib3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.annonc.2024.08.2330","article-title":"Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study","volume":"35","author":"Long","year":"2024","journal-title":"Ann Oncol"},{"key":"2026090103080751800_bib4","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"2026090103080751800_bib5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1470-2045(16)30126-7","article-title":"Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial","volume":"17","author":"Weber","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026090103080751800_bib6","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"2026090103080751800_bib7","doi-asserted-by":"publisher","first-page":"e003853","DOI":"10.1136\/jitc-2021-003853","article-title":"Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses","volume":"10","author":"Friedman","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026090103080751800_bib8","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1200\/JCO.21.00079","article-title":"Pembrolizumab plus ipilimumab following anti-PD-1\/L1 failure in melanoma","volume":"39","author":"Olson","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026090103080751800_bib9","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1038\/s41591-023-02498-y","article-title":"Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial","volume":"29","author":"VanderWalde","year":"2023","journal-title":"Nat Med"},{"key":"2026090103080751800_bib10","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science"},{"key":"2026090103080751800_bib11","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat Med"},{"key":"2026090103080751800_bib12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"2026090103080751800_bib13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"2026090103080751800_bib14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ccell.2023.03.010","article-title":"Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma","volume":"41","author":"Campbell","year":"2023","journal-title":"Cancer Cell"},{"key":"2026090103080751800_bib15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ccell.2025.01.009","article-title":"Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma","volume":"43","author":"Schiantarelli","year":"2025","journal-title":"Cancer Cell"},{"key":"2026090103080751800_bib16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"2026090103080751800_bib17","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1038\/s41467-024-47425-y","article-title":"Molecular patterns of resistance to immune checkpoint blockade in melanoma","volume":"15","author":"Lauss","year":"2024","journal-title":"Nat Commun"},{"key":"2026090103080751800_bib18","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1158\/1078-0432.CCR-23-0099","article-title":"HLA class II loss and JAK1\/2 deficiency coevolve in melanoma leading to CD4 T-cell and IFNgamma cross-resistance","volume":"29","author":"Stupia","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026090103080751800_bib19","doi-asserted-by":"publisher","first-page":"eabb0152","DOI":"10.1126\/scitranslmed.abb0152","article-title":"Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma","volume":"12","author":"Kalbasi","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026090103080751800_bib20","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1158\/2326-6066.CIR-23-0139","article-title":"Antitumor immune responses in B2M-deficient cancers","volume":"11","author":"Torrejon","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"2026090103080751800_bib21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas Network","year":"2015","journal-title":"Cell"},{"key":"2026090103080751800_bib22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"2026090103080751800_bib23","doi-asserted-by":"publisher","first-page":"btae425","DOI":"10.1093\/bioinformatics\/btae425","article-title":"A spatial Omnibus test (SPOT) for spatial proteomic data","volume":"40","author":"Samorodnitsky","year":"2024","journal-title":"Bioinformatics"},{"key":"2026090103080751800_bib24","doi-asserted-by":"publisher","first-page":"11720","DOI":"10.1038\/s41598-018-29604-2","article-title":"ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes","volume":"8","author":"Figenschau","year":"2018","journal-title":"Sci Rep"},{"key":"2026090103080751800_bib25","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"2026090103080751800_bib26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"2026090103080751800_bib27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","article-title":"Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling","volume":"179","author":"Coppola","year":"2011","journal-title":"Am J Pathol"},{"key":"2026090103080751800_bib28","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","article-title":"Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"key":"2026090103080751800_bib29","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"2026090103080751800_bib30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","article-title":"A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade","volume":"24","author":"Thommen","year":"2018","journal-title":"Nat Med"},{"key":"2026090103080751800_bib31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2026090103080751800_bib32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/modpathol.2016.28","article-title":"Plasma cells in primary melanoma. Prognostic significance and possible role of IgA","volume":"29","author":"Bosisio","year":"2016","journal-title":"Mod Pathol"},{"key":"2026090103080751800_bib33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026090103080751800_bib34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2026090103080751800_bib35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat Methods"},{"key":"2026090103080751800_bib36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12859-017-1544-9","article-title":"3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2026090103080751800_bib37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41587-021-01094-0","article-title":"Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning","volume":"40","author":"Greenwald","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2026090103080751800_bib38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell Program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"2026090103080751800_bib39","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","article-title":"Cell2location maps fine-grained cell types in spatial transcriptomics","volume":"40","author":"Kleshchevnikov","year":"2022","journal-title":"Nat Biotechnol"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-25-1745\/3772211\/cd-25-1745.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/doi\/10.1158\/2159-8290.CD-25-1745\/3820639\/cd-25-1745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/9\/1801\/3824576\/cd-25-1745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/16\/9\/1801\/3824576\/cd-25-1745.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:09:01Z","timestamp":1788246541000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/9\/1801\/787679\/Cellular-Neighborhoods-Govern-Antitumor-T-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,4,21]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-25-1745","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}